Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
This is a report on off-label extended use of rFVIIa in managing pulmonary, vesical and GI haemorrhage in 3 patients post-BMT, who failed to respond to blood component transfusion and […]